Kayne Anderson Rudnick Investment Management LLC Sells 10,820 Shares of Chemed Co. (NYSE:CHE)

Kayne Anderson Rudnick Investment Management LLC lowered its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 582,134 shares of the company's stock after selling 10,820 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned 3.87% of Chemed worth $308,415,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Parr Mcknight Wealth Management Group LLC bought a new stake in Chemed in the 4th quarter worth approximately $917,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Chemed by 5.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 48,197 shares of the company's stock worth $25,535,000 after acquiring an additional 2,277 shares in the last quarter. Voloridge Investment Management LLC boosted its stake in shares of Chemed by 201.3% in the 4th quarter. Voloridge Investment Management LLC now owns 11,626 shares of the company's stock valued at $6,159,000 after purchasing an additional 7,767 shares in the last quarter. Vident Advisory LLC boosted its stake in shares of Chemed by 112.4% in the 4th quarter. Vident Advisory LLC now owns 1,340 shares of the company's stock valued at $710,000 after purchasing an additional 709 shares in the last quarter. Finally, Twinbeech Capital LP bought a new position in shares of Chemed during the 4th quarter valued at $2,506,000. 95.85% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have weighed in on CHE shares. Wall Street Zen raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada boosted their target price on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th.

Chemed Stock Down 0.2%

Shares of Chemed stock traded down $1.11 on Thursday, hitting $571.90. The stock had a trading volume of 62,410 shares, compared to its average volume of 103,171. Chemed Co. has a one year low of $512.12 and a one year high of $623.61. The stock's 50-day simple moving average is $582.04 and its two-hundred day simple moving average is $565.74. The stock has a market cap of $8.37 billion, a price-to-earnings ratio of 28.90, a PEG ratio of 2.15 and a beta of 0.59.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same quarter in the prior year, the company posted $5.20 EPS. The firm's revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, equities analysts predict that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. Chemed's dividend payout ratio is presently 9.74%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at $62,566,139.07. This trade represents a 0.97% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $577.99, for a total transaction of $866,985.00. Following the transaction, the executive vice president now directly owns 14,627 shares of the company's stock, valued at approximately $8,454,259.73. This trade represents a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,500 shares of company stock valued at $4,401,120 in the last 90 days. Insiders own 3.29% of the company's stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.